Inappropriate billing for durable medical equipment (DME) continues to be among the most prevalent fraud, waste, and abuse (FWA) schemes in healthcare, with the Department of Justice regularly announcing new indictments for DME-related cases that aim to defraud both public and private payers. In one recent case, Cotiviti’s special investigations unit (SIU) identified a licensed DME provider that was not manufacturing its own equipment in many cases, but rather having it dropshipped from a large online retailer directly to the patient, then billing the health plan at a heavily marked-up rate.
Through data analysis, peer comparisons, and documentation requests, Cotiviti’s credentialed investigators were able to identify these inappropriate claims—and put a stop to future problematic billing to prevent more overpayments.
In reviewing a licensed DME company’s 12-month billing history for a health plan client, Cotiviti’s SIU identified several potentially problematic areas that warranted further investigation:
Cotiviti’s investigators then performed peer comparisons with other DME providers, identifying the suspect company as an outlier for these procedure codes.
While the investigation continued, Cotiviti placed the provider on prepay review for several procedure codes, including A4216 (sterile water, saline, or other drug diluent); A6196, A6197, A6198, and A6199 (alginate or other fiber gelling dressings); and L4361 (walking boot). Over nine months, Cotiviti reviewed approximately 130 claim lines, with the provider failing to produce documentation for 38% of these lines.
Overall, nearly 80% of reviewed claim lines resulted in denials due to documentation issues, including:
Finally, investigators found the provider was submitting receipts for DME from a major online retailer along with its claims, but billing the health plan nearly 70% more than the original purchase price. In total, these findings resulted in more than $11,000 in future inappropriate payments being prevented, while the case was referred back to the plan to perform provider education.
With due diligence, health plans can protect their members by helping to ensure they are being prescribed DME appropriately. Here are several key considerations to keep in mind:
Cotiviti’s prospective and retrospective 360 Pattern Review™ solution empowers health plans with automated, machine-learning powered detection of suspect billing behaviors for true FWA prevention and management across the entire claim payment cycle. Read our fact sheet and learn how we identify potential fraud cases earlier with a 360-degree view of provider billing.